We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

70 hedge funds and large institutions have $229M invested in Albireo Pharma Inc in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more call options, than puts

Call options by funds: $101K | Put options by funds: $43K

47% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 19

26% more capital invested

Capital invested by funds: $181M → $229M (+$47.8M)

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

1% more funds holding

Funds holding: 69 → 70 (+1)

Holders
70
Holders Change
+1
Holders Change %
+1.45%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
28
Reduced
19
Closed
9
Calls
$101K
Puts
$43K
Net Calls
+$58K
Net Calls Change
+$388K

Top Buyers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
+$4.87M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.48M
3
EP
Eversept Partners
New York
+$1.2M
4
BlackRock
BlackRock
New York
+$678K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$656K

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$4.6M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$2.94M
3
Man Group
Man Group
United Kingdom
-$1.97M
4
CC
Chicago Capital
Illinois
-$945K
5
HA
Heartland Advisors
Wisconsin
-$660K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$923K +$55K +2,750 +8%
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$864K +$656K +32,783 +2,705%
Prudential Financial
28
Prudential Financial
New Jersey
$843K +$2.1K +105 +0.3%
Charles Schwab
29
Charles Schwab
California
$726K +$71K +3,549 +14%
PPA
30
Parametric Portfolio Associates
Washington
$724K +$175K +8,771 +45%
AA
31
ALPS Advisors
Colorado
$655K +$8.36K +418 +2%
Squarepoint
32
Squarepoint
New York
$560K -$4K -200 -0.9%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$446K +$351K +17,555 New
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$438K +$345K +17,237 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$431K – – –
UBS Group
36
UBS Group
Switzerland
$417K +$129K +6,445 +65%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$394K – – –
PC
38
PA Capital
Virginia
$388K -$4.78K -239 -2%
Deutsche Bank
39
Deutsche Bank
Germany
$386K -$348K -17,405 -53%
Morgan Stanley
40
Morgan Stanley
New York
$383K +$234K +11,722 +352%
Wells Fargo
41
Wells Fargo
California
$341K -$111K -5,565 -29%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$337K +$1.84K +92 +0.7%
WG
43
Winton Group
United Kingdom
$337K +$265K +13,242 New
MCM
44
MAI Capital Management
Ohio
$316K +$249K +12,430 New
AGM
45
Alpine Global Management
New York
$309K +$243K +12,161 New
Barclays
46
Barclays
United Kingdom
$277K +$110K +5,521 +103%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$262K +$206K +10,300 New
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$259K – – –
Goldman Sachs
49
Goldman Sachs
New York
$256K -$400K -19,993 -67%
Marshall Wace
50
Marshall Wace
United Kingdom
$246K +$155K +7,772 +413%
1
2
3 4

ALBO Hedge Fund Activity: Q4 2019 in Review

70 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2019, worth a combined $229M — up 26% from $181M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ALBO positions and 9 closed out — a net gain of 2 holders — while 28 added to existing stakes and 19 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $4.87M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $4.6M.

  • 70 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2019, up from 69 in Q3 2019.
  • Funds reported $229M of Albireo Pharma Inc stock for Q4 2019, up 26% quarter-over-quarter.
  • 11 funds opened new Albireo Pharma Inc positions in Q4 2019 and 9 closed out, a net change of +2 holders.
  • The largest Albireo Pharma Inc buyer in Q4 2019 was ArrowMark Colorado Holdings, an estimated $4.87M added.
  • The largest Albireo Pharma Inc seller in Q4 2019 was TPG Group Holdings (SBS) Advisors, an estimated $4.6M sold.

Based on aggregated 13F filings for Q4 2019.